Power Outages May Increase Risk for Hospitalization Among Older U.S. Adults
Medically reviewed by Drugs.com
via HealthDayMONDAY, March 16, 2026 -- Power outages may increase the risk for hospitalization among older U.S. adults, according to a study published online March 12 in PLOS Medicine.
Heather McBrien, from the Columbia University Mailman School of Public Health in New York City, and colleagues examined if power outages (of at least eight hours in duration in 2018) are associated with emergency cardiovascular disease (CVD)-related and respiratory disease-related hospitalizations among older U.S. adults. The researchers used a national dataset of power outage exposure and Medicare Fee-for-Service beneficiaries to estimate daily county-level rates of emergency CVD- and respiratory-related hospitalizations.
The researchers found that power outages were associated with increased emergency CVD and respiratory hospitalizations, with 4,246 excess hospitalizations due to power outages. The association with CVD hospitalization was strongest the day after power outage exposure (rate ratio [RR], 1.02), while the association between outage and respiratory disease was strongest the day of power outage exposure (RR, 1.03).
"With outage frequency and duration increasing due to climate change, these outages may pose a growing threat to the cardiovascular and respiratory health of older adults," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-17 01:56
Read more
- New Flu Strain Weakened This Year’s Vaccine Protection, CDC Says
- ACC: Expanding Eligibility for Low-Income Subsidies Can Improve CVD Medication Adherence
- Johnson & Johnson Announces U.S. FDA Approval of Tecvayli plus Darzalex Faspro for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line
- Risk of Heat-Linked Emergency Department Use May Start at Lower Temperatures
- Machine Learning Model Can Predict Hepatocellular Carcinoma Risk
- More Than 250,000 Global Deaths From Meningitis Reported in 2023
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions